Variables | Total cohort (nā=ā338) | BCLC 0/A HCC (nā=ā205) | BCLC B/C HCC (nā=ā133) |
---|---|---|---|
Age, yearsā | 52 (44ā66) | 52 (44ā60) | 52 (43ā60) |
Male genderā” | 299 (88.5) | 180 (87.5) | 119 (89.5) |
Positive HBsAgā” | 278 (82.2) | 170 (82.9) | 108 (81.2) |
Total bilirubin, Ī¼mol/lā | 14.0 (13.4ā19.4) | 13.9 (10.0ā19.6) | 14.4 (10.6ā18.7) |
Albumin, g/lā | 37.9 (35.1ā40.8) | 38.0 (35.4ā41.0) | 37.6 (34.0ā40.7) |
ALT, U/lā | 36.1 (25.8ā52.0) | 34.3 (24.7ā53.0) | 37.9 (26.4ā51.0) |
Prothrombin time, sā | 13.2 (12.0ā14.1) | 13.2 (12.0ā14.1) | 13.2 (12.1ā14.1) |
INRā | 1.04 (0.95ā1.14) | 1.04 (0.94ā1.14) | 1.05 (0.95ā1.14) |
Platelet count, Ćā109/lā | 155 (110ā205) | 155 (110ā211) | 154 (113.5ā201.5) |
Maximum tumor size, cmā | 6.0 (4.2ā10.0) | 6.0 (3.5ā9.2) | 8 (5.0ā11.0) |
Serum AFP, ng/mlā” | |||
āā„ā400 | 141 (41.7) | 73 (35.6) | 68 (51.1) |
ā<ā400 | 197 (58.3) | 132 (64.4) | 65 (48.9) |
CSPHā” | 56 (16.6) | 34 (16.6) | 22 (16.5) |
ALBI scoreā | āā2.460 (āā2.704ā āā2.192) | āā2.518 (āāā2.719āāā2.236) | āā2.399 (āā2.702āāā2.136) |
ALBI gradeā” | |||
ā1 | 134 (39.6) | 89 (43.4) | 45 (33.8) |
ā2 | 198 (58.6) | 114 (55.6) | 84 (63.2) |
ā3 | 6 (1.8) | 2 (1.0) | 4 (3.0) |
MELD score (range) | 7 (6ā18) | 7 (6ā18) | 7 (6ā17) |
MELD scoreā” | |||
āā„ā9 | 88 (26.0) | 47 (22.9) | 41 (30.8) |
ā<ā9 | 250 (74.0) | 158 (77.1) | 92 (69.2) |
Child-Pugh gradeā” | |||
āA | 308 (91.1) | 190 (92.7) | 118 (88.7) |
āB | 30 (8.9) | 15 (7.3) | 15 (11.3) |
āC | 0 (0) | 0 (0) | 0 (0) |
BCLC stageā” | |||
ā0 | 12 (3.6) | ā | ā |
āA | 193 (57.1) | ā | ā |
āB | 82 (24.3) | ā | ā |
āC | 51 (15.1) | ā | ā |